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ABSTRACT  
Background 
Estimates of health-related quality of life (HRQoL) and work/school absences for influenza are 
typically based on medically-attended cases or those meeting influenza-like-illness (ILI) case 
definitions, and thus biased towards severe disease.  Although community influenza cases are more 
common, estimates of their effects on HRQoL and absences are limited. 
Objectives 
To measure Quality-Adjusted Life Days and Years (QALDs and QALYs) lost and work/school absences 
among community cases of acute respiratory infections (ARI), ILI and influenza A and B and to 
estimate community burden of QALY loss and absences from influenza.  
Patients/ methods 
Flu Watch was a community cohort in England from 2006–2011.  Participants were followed-up 
weekly.  During respiratory illness they prospectively recorded daily symptoms, work/school 
absences and EQ-5D-3L data and submitted nasal swabs for RT-PCR influenza testing. 
Results 
Average QALD lost was 0.26, 0.93, 1.61 and 1.84 for ARI, ILI, H1N1pdm09 and influenza B cases 
respectively.  40% of influenza A cases and 24% of influenza B cases took time off work/school with 
an average duration of 3.6 days and 2.4 days respectively.  In England, community influenza cases 
lost 24,300 QALYs in 2010/11 and had an estimated 2.9 million absences per season based on data 
from 2006/07 – 2009/10. 
Conclusions 
Our QALDs and QALYs lost and work and school absence estimates are lower than previous 
estimates because we focus on community cases, most of which are mild, may not meet ILI 
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definitions and do not result in healthcare consultations. Nevertheless, they contribute a substantial 
loss of HRQoL on a population level. 
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INTRODUCTION 
Influenza epidemics have a major social and economic impact. As well as direct healthcare costs, 
influenza may lead to other indirect effects including school absenteeism, loss of workplace 
productivity and effects on health-related quality of life (HRQoL)(1). The quality of life of both 
patients and their families may be affected, especially when the patient is a child(2). Quantifying 
indirect effects accurately is essential to inform cost utility analyses (CUA) of interventions to 
mitigate the population impact of influenza, including extension of seasonal vaccination policies. 
  
In the United Kingdom, the National Institute for Health and Care Excellence (NICE) recommends 
that health effects of interventions are expressed in terms of Quality-Adjusted Life Years (QALYs) as 
this generic measure of health benefits reflect both mortality and HRQoL(3). The standardised 
validated tool EQ-5D(4) is NICE’s preferred measure of HRQoL(3). NICE use a cost utility threshold of 
£20,000-30,000 per QALY to judge whether or not interventions are deemed cost effective. 
 
A systematic review of HRQoL in influenza showed a paucity of studies that used standardised well-
validated methods to generate estimates of the Quality-Adjusted Life Days (QALDs) lost(5). It 
identified four previous estimates of QALDs lost due to influenza, which varied from 1.57 to 10.69 
depending on the population sampled and method of HRQoL measurement used(6-9).  Many of 
these studies did not measure HRQoL throughout the duration of illness. They tended to measure 
HRQoL once at baseline and once on the worst day of illness, which required assumptions to be 
made about the shape of the QALY loss over an illness(5). 
 
Studies that measure HRQoL and work and school absence from influenza cases seeking medical 
attention may overestimate the indirect cost per case. A systematic review of studies of children’s 
absences from school and daycare due to influenza showed a gradient of days lost, with the longest 
absences reported by cases attending hospital emergency departments, then those in physician 
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office-based studies followed by community cases(10).  Additionally, studies that estimate the 
population level burden of HRQoL and absences from only severe cases miss the majority of 
influenza illnesses which, despite their mild nature, are likely to contribute substantially to the 
overall burden(5, 11).  Although household studies may capture these milder illnesses that do not 
result in health-seeking behaviour, and therefore provide less biased estimates, their specificity is 
often limited by a lack of laboratory-confirmed diagnoses.  
 
There is therefore a need for robust estimates of the indirect effects of influenza from community 
studies identifying illnesses through prospective active symptom and molecular surveillance. We 
have previously described the community burden of influenza, ILI and acute respiratory infections 
not meeting the definition of ILI across multiple influenza seasons in a large household cohort in 
England(12). Here we present the effects of these illnesses on HRQoL and work/school absences 
using the same cohort.  We also estimate the population-level burden of these outcomes among 
community influenza cases.  
 
METHODS  
Study Design  
Flu Watch is a previously described, household-based, community cohort study of acute respiratory 
disease and influenza infection in England(12, 13).  In brief, the study followed up cohorts during six 
influenza seasons including 3 periods of seasonal influenza (winters 2006-07, 2007-08 and 2008-09) 
and the first three waves of the 2009 influenza pandemic (summer 2009, autumn-winter 2009/10 
and winter 2010/11).  In total 5484 participants were followed up for 118,158 person-weeks.  
Individuals were randomly recruited through primary care practices and their households invited to 
participate.  Participants gave written informed consent and parents/guardians gave proxy consent 
for children.  The Flu Watch study was approved by the Oxford MultiCentre Research Ethics 
committee (06/Q1604/103). 
 6 
 
Baseline surveys collected demographic, socio-economic and occupation data.  Participants were 
categorised into ‘working’ (employed full-time, part-time or self-employed), ‘students’ (self-
classified, aged 5-15) and ‘not in work/education’. Participants were contacted weekly and asked to 
record any “cough, cold, sore throat, or flu-like illness” which we define as an acute respiratory 
illness.  During these illnesses, participants reported daily symptoms and temperature 
measurements using prospective illness diaries.  Parents/guardians completed surveys on behalf of 
their children as needed. Self-administered nasal swabs were requested on day two of any illness. 
Participants submitted the swabs by mail to be tested for circulating influenza A viruses (H1N1, 
H3N2 and from 2009 onwards H1N1pdm09), and influenza B viruses using RT-PCR(14, 15). 
 
HRQoL Outcomes 
Between 2006/07 and 2009/10 illness diaries included daily questions on whether the ill individual 
had taken time off work/school.  In 2006/07 through 2008/09 and for a subset of participants in 
2009/10, illness diaries also asked whether someone else took time off on that day to care for them.  
During 2009/10 time off was quantified as ≤4 hours or >4 hours. In 2010/11 QALDs and QALYs were 
measured using the EQ-5D-3L instrument(16-18), which was completed at baseline and daily 
throughout illness.  Designed for self-completion, EQ-5D-3L has two components.  The first describes 
health across five domains: mobility, self-care, usual activities, pain and anxiety. Participants rate 
each domain as ‘no problems’, ‘some problems’ or ‘extreme problems’.  Participants also record 
their overall health status on a visual analogue scale (EQ-VAS) from 0 (Worst imaginable health 
state) to 100 (Best imaginable health state). The online EQ-VAS question used in Flu Watch however 
asked participants to rate their health without the visual scale.  The three possible responses for 
each of the five EQ-5D-3L domains results in 35 possible health states. These health states were 
mapped to an index value (representing a QALD weight) using a validated UK value set(18).  The 
QALD weights range between 1 (full health) to 0 (dead).   
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Illness outcomes 
All acute respiratory illnesses, regardless of swabbing or PCR result, were classified into two 
symptomatic outcomes.  Those with confirmed fever (≥37.8°C) or symptoms of ‘feeling feverish’ and 
either a cough or sore throat at any point were classified as Influenza-like-illnesses (ILI).  All other 
acute respiratory illnesses were classified as acute respiratory infections (ARI).  Among the illnesses 
that had an accompanying swab, some were confirmed as PCR+ influenza cases and these were 
grouped into influenza A and influenza B viruses.  In 2010/11 when the EQ-5D-3L data was collected, 
all influenza A illnesses were H1N1pdm09, apart from one H3N2 case.  The individual-level results 
report QALD loss for H1N1pdm09 cases only but the population projections include H3N2. 
 
Statistical analysis 
Time off work/education 
The illness duration, percentages of illnesses with time off and mean number of days taken off  were 
calculated for each illness outcome and stratified by age group and employment status.  The latter 
two estimates were done separately for time off taken by the ill person, by someone caring for the ill 
person and a combination of both.   
 
HRQoL 
Within each illness, the worst day of illness within each domain was identified.  The percentage of 
respondents reporting no, some or extreme problems on their worst day in each domain was 
compared to the corresponding baseline responses, stratified by illness outcome.   
Within each illness, the worst day for EQ-VAS and the worst day for QALD weight were identified.  
For each illness outcome, mean and median worst day EQ-VAS scores and QALD weights were 
calculated and compared to baseline measurements.    
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Total QALD loss for each illness was calculated by subtracting the daily QALD weights taken during 
illness from the participant’s baseline QALD weight and summing these differences up over the 
course of the illness.  Mean and median total QALD and QALY losses per illness were calculated by 
illness outcome and stratified by age group and whether or not cases were medically-attended.      
A sensitivity analysis was also conducted using the respondents’ highest reported QALD weight as 
the comparison (baseline) group, regardless of when it was measured. 
 
Missing data 
If a participant’s baseline questionnaire was missing then QALDs and QALYs could not be estimated 
for their subsequent illnesses.  All illnesses with daily EQ-5D-3L measurements were included in the 
duration of illness, worst day EQ-VAS and QALD weight estimates.  If a participant failed to complete 
illness diaries throughout their illness then their illness duration would be truncated. We also 
investigated whether influenza cases actively reported no illness in the week following the last 
reported day of illness, or whether this weekly report was missing.    
 
Population impact 
We estimated the total QALY loss experienced by community cases in the population and the 
number of days they took time off work/school due to influenza.  Estimates were obtained from Flu 
Watch data by taking 25,000 Monte Carlo samples from the distributions of incidence of illness and 
QALD losses, or days off work, as appropriate, for each age-group.  The incidence of illness and 
HRQoL outcomes for the QALY analysis were derived from 2010/11 data while estimates for the 
absence analysis came from 2006/07-2009/10.  The mid-2011 population size and age-distribution 
for England was used(19).  
 
RESULTS 
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2919 participants reported 4818 illnesses (2805 ARI and 2013 ILI) (Table 1).  Of the 3161 illnesses 
with nasal swabs, 177 tested positive for influenza A and 45 for influenza B.  75% of influenza A cases 
meet our ILI case definition however only 48% reported fever (a symptom required for many ILI 
definitions).  For influenza B, 80% of cases met our ILI definition but only 60% reported fever.  Most 
influenza B cases were in children whereas most influenza A cases were in adults.  25% of influenza A 
cases and 14% of influenza B cases were medically-attended either through the government run 
pandemic influenza web or phone service (which ran during 2009/10), the NHS Direct telephone 
service, or contact with a GP, accident and emergency department or hospital.   
 
Time off work/education 
Average illness duration, percentages of illnesses with time off, and the symptom number of days 
per illness with time off were broadly comparable between influenza A and B cases although 
influenza A appeared slightly more severe (Table 2).  Illness duration was 9.6 and 10.7 days for 
influenza A and B respectively.  Among cases where absence data was available for both the ill 
participant and those caring for them, 50% of Influenza A and 41% of Influenza B cases required at 
least one person to take time off for a combined average of 5.0 and 3.4 days respectively.  Among ill 
children, 56% and 31% took time off school or childcare for an average duration of 3.5 and 2.1 days 
for influenza A and B respectively.  Among the subset of data where information was available, 70% 
and 42% of children’s illnesses required someone else to take time off to care for them.  Ill adults 
were less likely to take time off (31% and 20% for influenza A and B respectively) but took more time 
off (3.8 and 3.0 days for influenza A and B respectively).  Estimates remained similar when limited to 
working adults aged 16 and over.  ILI cases were broadly comparable with influenza cases although 
more severe than the ARI cases.  For the 142 influenza illnesses where the amount of time taken off 
per day was measured, 83% of days had more than 4 hours off.   
 
EQ-5D-3L 
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Those reporting problems and problem severity on the worst day of illness were broadly similar 
between H1N1pdm09, influenza B and ILI (Figures 1 a-d).  The most affected domains were ‘usual 
activities’ and pain, followed by mobility, but all domains were affected.   
 
The median and mean EQ-VAS background scores were between 84-90 for H1N1pdm09, influenza B 
and ILI, but dropped to between 40-50 on the worst day of illness (Figure 2, Table 3). Mean QALD 
weights were 0.93 and 0.92 at baseline for H1N1pdmo09 and influenza B respectively but dropped 
to 0.44 and 0.36 on the worst day of illness (Table 3). Median QALD weight for H1N1pdm09 (0.73) 
was much higher than the corresponding mean (0.44) suggesting that a few severe illnesses were 
greatly contributing to the mean (Figure 2 , Table 3).   
 
For H1N1pdm09 and influenza B, daily EQ-VAS and QALD weights varied throughout illness, with a 
rapid decline in the first 2 days (Figures 3a-b).  The lag time between symptom onset and the most 
severe day of illness appeared longer for H1N1pdm09 than for influenza B.  Although the medians 
remain relatively low for the first week, over time these estimates reflected fewer illnesses, i.e. 
those with the longest duration (see bottom panels, Figures 3a-b).    
 
Average illness duration for H1N1pdm09 and influenza B cases with QALD data was 8.8 and 11.9 
days respectively, with 3% and 9% of illnesses respectively lasting over three weeks.  Overall 1.61 
QALDs were lost during H1N1pdm09 illnesses.  QALD loss increased with age from 1.08 in children, 
to 1.74 and 1.75 in adults and the older adults respectively.  Influenza B illnesses lost more QALDs at 
1.84 with age-specific estimates of 1.82, 2.37 and 0.95 for children, adults and older adults 
respectively.  QALD loss during ILI and ARI illnesses were lower (0.26 and 0.93 respectively).   Median 
QALD loss was typically lower than the mean for all illness outcomes, indicating that a small 
proportion of severe illnesses contributed greatly to the mean. 19% of H1N1pdm09 and 17% of 
influenza B cases with QALD/QALY data were medically-attended.  Mean QALD loss was 3.63 for 
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medical-attended H1N1pmd09 cases and 1.08 for non-medically-attended cases.  Corresponding 
figures for influenza B were 5.48 and 1.23.  
 
In sensitivity analysis, overall QALDs lost were higher at 1.89 for H1N1pdm09 and 2.64 for influenza 
B.  Age-specific sensitivity estimates were similar to the main analysis except in the oldest age group 
where the sensitivity analysis reports higher QALD losses. 
 
Missing Data 
One H1N1pdm09 and two influenza B illnesses were missing baseline EQ-5D-3L measurements. 
Among the 57 influenza cases with QALD data, all but two reported no illness in the week following 
their illness.   
 
Population Impact 
The estimated number of QALYs lost due to influenza A and B in England was 24,300 (95%CI: 
16,600–34,700), of which two-thirds occurred in the 16-64 years age-group (Table 4). The estimated 
number of days off school in individuals aged 5-15 years with influenza was 1.12 million (95%CI: 
0.661–1.78 million) per winter, of which 85% was associated with influenza A. The estimated 
number of days off work or education in individuals aged 16-64 years with influenza was 1.79 million 
(95%CI: 1.16 – 2.78 million), almost all of which (>98%) was due to influenza A. 
 
DISCUSSION 
Summary of results 
We estimate that community cases of ARI, ILI, H1N1pdm09 and influenza B lose 0.25, 0.93, 1.61 and 
1.84 QALDs from their illnesses respectively.  Our estimated QALDs lost increased with age which is 
consistent with previous findings(8). Mean QALD loss was much greater in medically-attended 
H1N1pdm09 and influenza B cases (3.63 and 5.48 respectively) compared to non-medically-attended 
 12 
 
cases (1.08 and 1.23 respectively). We found 50% of influenza A illnesses and 41% of influenza B 
illness required someone (ill participant and/or their carer) to take time off work/education for a 
combined average of 5.0 and 3.4 days. Compared with adults, children with influenza were more 
likely to take time off education/childcare and to require someone else to take time off to care for 
them.  Around a third of working adults required time off work for both influenza A and B illnesses 
with an average of 4 and 3 days off respectively.  Illness duration and time off estimates for ILI were 
comparable to influenza but higher than ARI.  In England, community influenza cases lost 24,300 
QALYs (8.87 million QALDs) in 2010/11 and had an estimated 2.9 million absences per season based 
on data from 2006/07 – 2009/10. 
 
Comparison to other studies 
Previous studies show substantial variation in the HRQoL associated with influenza. This reflects 
differences in subjects’ ages, definitions and severity of illness as well as the methods used to 
estimate HRQoL. Several estimates have been derived from cases seeking medical attention. In a 
population-based study conducted in England during the 2009 pandemic using EQ-5D-3L, 2.92 
QALDs were lost for confirmed cases of H1N1pdm09 and 2.74 for ILI controls(5).  Another study 
reported a QALD loss of 1.68 for ILI due to confirmed influenza and 1.57 for non-influenza ILI in adult 
patients(9). This was calculated by subtracting VAS scores presented by O’Brien et al(20) from 
pooled oseltamivir trial data  in nearly 640 ILI patients who received placebo, from a baseline quality 
of life weight. A study used data from the same trials to estimate the QALD loss associated with ILI as 
5.33 in people aged 0-19 years, 6.35 in people aged 20-64 years and 10.69 for people aged 65 years 
and over by combining the published QALY weights with unpublished data on disease duration(8). 
Finally, a study of patients from hospitals and primary care centres with confirmed H1N1pdm09 in 
Spain showed individual QALD losses of 3.29 for primary care patients and 11.3 for hospitalised in-
patients(11).    
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There are fewer studies of community influenza cases that may not consult healthcare professionals. 
Nevertheless, a survey in England of caregivers of children in primary school reporting ILI outbreaks 
that used EQ-5D-3L  showed a mean loss of 2.1 QALDs(1). In Belgium, a household telephone survey 
including 2,250 individuals with self-reported ILI used SF-12 to calculate QALDs lost: for an average 
episode of illness in the community, 1.83 QALDs were lost(21).   
 
In general, our estimates for individual-level QALDs lost due to influenza were lower than earlier 
findings. This is unsurprising, as our study captured mild illnesses including cases of confirmed 
influenza that neither consulted for care nor met the symptom definition of ILI.  Additionally, our 
study included children who typically have less severe disease as well as a large number H1N1pdm09 
cases which in our cohort were less severe than H3N2 cases(22).  This work and previous studies 
have shown that more QALDs are lost when estimates are derived from medically-attended case, 
and in particular hospitalised cases.  Our findings for work and school absences were also generally 
lower than previous estimates; for most illnesses, people did not take time off, although there were 
differences by age and illness definition. We showed however, that illness in a household member 
caused a substantial proportion of people take time off work to care for unwell household members. 
A study in the US on school and parental absenteeism showed that for every three days a child took 
off school a parent missed on average one day of work(23).  
 
The aforementioned British and Spanish studies are not directly comparable as they estimated the 
population-level burden of QALY loss due to influenza for more severe cases in a different season 
(2009/10)(5, 11).  They do however contextualise our findings as they report burden of QALY loss 
due to hospitalisations and deaths, which when combined with our results for community cases 
provides an indication of the scale of QALYs lost in a given season and the proportion attributable for 
different levels of disease severity.  For example, the British study estimated that 40% 
(approximately 11,000 QALYs) of their total QALYs lost came from 337 reported influenza deaths(5).  
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Similarly the Spanish study estimated their 318 deaths lost 12,000 QALYs(11).  It also estimated 
burden of QALY loss for influenza in-patients and primary care patients, demonstrating that less 
severe yet more numerous primary care patients lost far more QALYs (6,778)  than the more severe 
but less common in-patients (94 QALYs).  Given these findings it seems that at least for these two 
seasons, the biggest contributors of population-level QALY loss are community cases (medically- and 
non-medically attended) and deaths.  The true burden and contribution by level of severity is likely 
to vary substantially between seasons and populations as it dependent on population size and age-
specific rates of illness and death.  The estimated burden is also highly dependent on severity of 
cases included in the model. 
 
Strengths and weaknesses 
Our estimates of HRQoL and work and school absence were derived from a large community cohort 
study using active molecular and symptom surveillance to identify episodes of influenza, ILI and ARI. 
We captured a broad spectrum of illnesses including mild cases of laboratory-confirmed influenza 
that did not meet the syndromic definition of ILI and/or did not consult a healthcare professional, 
which gave less biased estimates of the overall HRQoL and absences associated with influenza. A key 
strength was that participants completed the EQ-5D-3L daily over the course of an illness. This 
directly measures HRQoL throughout illness, so unlike other studies that used a single estimate of 
HRQoL during illness, we did not need to make assumptions about the shape of the QALY loss.  The 
estimates for our population projections were all derived from the same data source.   
 
Although we measured work and school absences over multiple years, HRQoL was only measured in 
2010/11 when influenza A H1N1pdm09 and influenza B strains circulated. We expect that, as H3N2 
was associated with more severe symptoms than H1N1, its effects on HRQoL might have been 
greater(12).  Despite the large cohort size, the numbers with confirmed influenza and EQ-5D were 
relatively low (N=58) and not sufficient to draw conclusions on differences in HRQoL by strain. The 
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uncertainty in our QALD and QALY estimates is reflected in the 95% confidence intervals of our 
population projections.  We previously showed that the majority of influenza infections are 
asymptomatic(12). Although asymptomatic cases would have no associated QALD loss, it is possible 
we failed to capture very mild cases that did not shed sufficient virus for PCR detection and thus 
slightly overestimated individual-level QALD loss associated with confirmed influenza.  Conversely, 
our population-level estimates should be considered minimum estimates because if we missed cases 
(for example from low viral shedding) this would reduce our estimated disease rates and thus overall 
burden estimates.  We found some people reported worse HRQoL at baseline than during illness and 
our sensitivity analysis showed that when we took the participants’ best reported measure of HRQoL 
as the comparison group, regardless of its timing, the oldest age group had much higher estimates of 
QALY loss.  A further limitation is that children’s HRQoL was reported by their parents. Previous 
studies show significant differences when both parents and adolescent measure children’s quality of 
life(24). Instruments such as EQ-5D-3L have not been validated for use in infants and very young 
children, which is a challenge of assessing HRQoL in this age group(25).   
 
Implications  
Estimates of QALDs lost and work and school absences associated with influenza differ depending on 
the setting in which cases are identified; community illnesses result in smaller effects but contribute 
substantially to the population-level burden. Accurate assessment of both the number of expected 
cases and their QALDs/QALYs is essential to inform CUAs for decision-making bodies such as NICE. 
While for some interventions, such as antiviral treatments of severe influenza cases, it is appropriate 
to use utility estimates derived from medically-attended cases, we believe that our estimates are 
more appropriate for assessing cost utility of community preventive interventions such as vaccines. 
 
Conclusions 
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We present new estimates of individual- and population-level QALDs and QALYs lost and work and 
school absences due to community cases of influenza to inform CUAs of community interventions to 
prevent influenza. 
 
 
  
 17 
 
Competing interests 
EBF, CWG, MZ, PJW and WJE report no conflicts of interest.  ACH is a member of the UK’s Joint 
Committee on Vaccination and Immunisation influenza subgroup and a member of the UK 
Department of Health New and Emerging Respiratory Viruses advisory group.  JSN-V-T reports 
research grants, unrelated to the present work from F. Hoffmann-La Roche and GlaxoSmithKline; 
consultancy for Prep Biopharm, and ACM Biolabs; and a travel grant from the European Scientific 
Working Group on Influenza (ESWI) to enable delivery of a plenary lecture. 
 
Financial statement 
The Flu Watch study was funded by MRC and the Wellcome Trust (G0600511, G0800767 and 
MC_U122785833).  CWG is supported by a Wellcome Intermediate Clinical Fellowship.  This work 
was supported by grants from the Medical Research Council (MR/K010174/1 to PJW), National 
Institute for Health Research (HPRU-2012-10080 to PJW), Engineering and Physical Sciences 
Research Council (EP/K031953/1 to ACH, EF, PJW).   
The views expressed are those of the authors and not necessarily those of the Department of Health, 
EPSRC, MRC, NIHR, NHS, Public Health England, or the Wellcome Trust. 
 
  
 18 
 
References 
1. Thorrington D, Balasegaram S, Cleary P, Hay C, Eames K. Social and Economic Impacts of 
School Influenza Outbreaks in England: Survey of Caregivers. The Journal of school health. 
2017;87(3):209-16. 
2. Chow MY, Morrow AM, Booy R, Leask J. Impact of children's influenza-like illnesses on 
parental quality of life: a qualitative study. Journal of paediatrics and child health. 2013;49(8):664-
70. 
3. Excellence NIfHaC. Guide to the methods of technology appraisal Internet2013 [Available 
from: nice.org.uk/process/pmg9. 
4. Szende A, Williams A. Measuring self-reported population health: an international 
perspective based on EQ5D. Internet2004. 
5. van Hoek AJ, Underwood A, Jit M, Miller E, Edmunds WJ. The impact of pandemic influenza 
H1N1 on health-related quality of life: a prospective population-based study. PloS one. 
2011;6(3):e17030. 
6. Griffin AD, Perry AS, Fleming DM. Cost-effectiveness analysis of inhaled zanamivir in the 
treatment of influenza A and B in high-risk patients. PharmacoEconomics. 2001;19(3):293-301. 
7. Prosser LA, Bridges CB, Uyeki TM, Hinrichsen VL, Meltzer MI, Molinari NA, et al. Health 
benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerging infectious 
diseases. 2006;12(10):1548-58. 
8. Sander B, Kwong JC, Bauch CT, Maetzel A, McGeer A, Raboud JM, et al. Economic appraisal 
of Ontario's Universal Influenza Immunization Program: a cost-utility analysis. PLoS medicine. 
2010;7(4):e1000256. 
9. Siddiqui MR, Edmunds WJ. Cost-effectiveness of antiviral stockpiling and near-patient testing 
for potential influenza pandemic. Emerging infectious diseases. 2008;14(2):267-74. 
10. Antonova EN, Rycroft CE, Ambrose CS, Heikkinen T, Principi N. Burden of paediatric influenza 
in Western Europe: a systematic review. BMC public health. 2012;12:968. 
11. Hollmann M, Garin O, Galante M, Ferrer M, Dominguez A, Alonso J. Impact of influenza on 
health-related quality of life among confirmed (H1N1)2009 patients. PloS one. 2013;8(3):e60477. 
12. Hayward AC, Fragaszy EB, Bermingham A, Wang L, Copas A, Edmunds WJ, et al. Comparative 
community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort 
study. Lancet Respir Med. 2014;2(6):445-54. 
13. Fragaszy EB, Warren-Gash C, Wang L, Copas A, Dukes O, Edmunds WJ, et al. Cohort Profile: 
The Flu Watch Study. Int J Epidemiol. 2016. 
14. Ellis J, Iturriza M, Allen R, Bermingham A, Brown K, Gray J, et al. Evaluation of four real-time 
PCR assays for detection of influenza A(H1N1)v viruses. Euro surveillance : bulletin Europeen sur les 
maladies transmissibles = European communicable disease bulletin. 2009;14(22). 
15. Stephenson I, Democratis J, Lackenby A, McNally T, Smith J, Pareek M, et al. Neuraminidase 
inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clinical 
infectious diseases : an official publication of the Infectious Diseases Society of America. 
2009;48(4):389-96. 
16. Brooks R. EuroQol: the current state of play. Health policy (Amsterdam, Netherlands). 
1996;37(1):53-72. 
17. Group E. EuroQol--a new facility for the measurement of health-related quality of life. 
Health policy (Amsterdam, Netherlands). 1990;16(3):199-208. 
18. Szende A, Oppe M, Devlin N. EQ-5D Value Sets: Inventory, Comparative Review and User 
Guide. Dordrecht; 2007. 
19. Statistics OfN. Annual Mid-year Population Estimates for England and Wales, Mid 2011 2011 
[Available from: 
http://webarchive.nationalarchives.gov.uk/20160108124536/http://www.ons.gov.uk/ons/rel/pop-
 19 
 
estimate/population-estimates-for-england-and-wales/mid-2011--2011-census-based-/stb---mid-
2011-census-based-population-estimates-for-england-and-wales.html. 
20. O'Brien BJ, Goeree R, Blackhouse G, Smieja M, Loeb M. Oseltamivir for treatment of 
influenza in healthy adults: pooled trial evidence and cost-effectiveness model for Canada. Value in 
health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 
2003;6(2):116-25. 
21. Bilcke J, Coenen S, Beutels P. Influenza-like-illness and clinically diagnosed flu: disease 
burden, costs and quality of life for patients seeking ambulatory care or no professional care at all. 
PloS one. 2014;9(7):e102634. 
22. Hayward AC, Fragaszy EB, Bermingham A, Wang L, Copas A, Edmunds WJ, et al. Comparative 
community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort 
study. The Lancet Respiratory medicine. 2014;2(6):445-54. 
23. Neuzil KM, Hohlbein C, Zhu Y. Illness among schoolchildren during influenza season: effect 
on school absenteeism, parental absenteeism from work, and secondary illness in families. Archives 
of pediatrics & adolescent medicine. 2002;156(10):986-91. 
24. Saigal S, Stoskopf BL, Feeny D, Furlong W, Burrows E, Rosenbaum PL, et al. Differences in 
preferences for neonatal outcomes among health care professionals, parents, and adolescents. 
Jama. 1999;281(21):1991-7. 
25. Prosser LA. Current challenges and future research in measuring preferences for pediatric 
health outcomes. The Journal of pediatrics. 2009;155(1):7-9. 
 
 20 
 
Table 1. Baseline Characteristics of ill participants 
 
n % n % n % n % n % n %
Overall 2919 100% 4818 100% 2805 100% 2013 100% 177 100% 45 100%
By influenza season
Winter 2006/07 270 9% 399 8% 146 5% 253 13% 14 8% 0 0%
Winter 2007/08 363 12% 539 11% 188 7% 351 17% 10 6% 4 9%
Winter 2008/09 219 8% 410 9% 123 4% 287 14% 40 23% 13 29%
Summer 2009 33 1% 110 2% 42 2% 68 3% 2 1% 0 0%
Winter 2009/10 1644 56% 2690 56% 1893 68% 797 40% 75 42% 5 11%
Winter 2010/11 390 13% 670 14% 413 15% 257 13% 36 20% 23 51%
By age group
0-15 years 647 22% 1203 25% 648 23% 555 28% 68 39% 26 58%
16-65 years 1806 63% 2892 61% 1723 62% 1169 59% 99 57% 15 33%
65 years and over 431 15% 679 14% 409 15% 270 14% 8 5% 4 9%
By IMD quartile*
1 (most deprived) 141 5% 238 5% 132 5% 106 5% 12 7% 3 7%
2 606 21% 1032 22% 544 20% 488 25% 49 28% 12 27%
3 1010 35% 1715 36% 1012 37% 703 36% 55 31% 14 31%
4 (least deprived) 1099 38% 1750 37% 1065 39% 685 35% 59 34% 16 36%
By occupation
In work 1288 51% 2052 46% 1267 51% 785 47% 62 41% 9 22%
Student 533 21% 932 21% 510 21% 422 25% 59 39% 25 61%
Not in work/school 724 28% 1172 26% 708 29% 464 28% 30 20% 7 17%
By sex
Female 1513 53% 2574 54% 1491 54% 1083 55% 89 51% 23 51%
Male 1343 47% 2161 46% 1262 46% 899 45% 86 49% 22 49%
*English Indices of Multiple Deprivations 2007
ARI ILI Influenza A PCR+ Influenza B PCR+
All IllnessesAll People All Illnesses
(N=4818)
Illnesses tested for Flu A & B
(N=3161)
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Table 2. Illness duration and time off work/education (Autumn 2006 – Spring 2010)
N Estimate N Estimate N Estimate N Estimate
Duration of symptoms, average (min, max) 2805  6.9 ( 1, 48) 2013  9.0 ( 1, 82) 177  9.6 ( 1, 82) 45 10.7 ( 1, 65)
Percent of i l lnesses where the i ll  participant and/or someone caring for them takes 
time off work/education/childcare* 458 11% 897 30% 64 50% 17 41%
Among i llnesses with anyone's time off:  Average number of days someone (regardless 
of who) takes time off work/education/childcare (min, max)* 51  2.5 ( 1,  6) 269  3.8 ( 1, 18) 32  5.0 ( 2, 11) 7  3.4 ( 2,  6)
Percent of i l l  participants taking time off work/education/childcare 2805 11% 2013 27% 177 40% 45 24%
Among i ll  participants taking time off: Average number of days they take time off 
work/education/childcare (min, max) 296  2.5 ( 1, 14) 545  3.2 ( 1, 18) 71  3.6 ( 1, 13) 11  2.4 ( 1,  4)
Percent of i l lnesses where someone else takes time off to care for i l l  participant* 458 4% 897 11% 64 28% 17 29%
Among i llnesses where someone else takes time off: Average number of days they take 
time off to care for il l  participant (min, max)* 19  1.4 ( 1,  3) 102  2.0 ( 1,  7) 18  2.7 ( 1,  6) 5  1.6 ( 1,  2)
Percent of i l l  children taking time off school/childcare for their i l lness 648 14% 555 39% 68 56% 26 31%
Among i ll  children taking time off: Average number of days they take time off 
school/childcare (min, max) 93  2.3 ( 1, 12) 218  2.9 ( 1, 13) 38  3.5 ( 1, 13) 8  2.1 ( 1,  4)
Percent of i l lnesses where someone else takes time off to care for i l l  chi ld* 78 10% 256 24% 20 70% 12 42%
Among i llnesses where someone else takes time off: Average number of days they take 
time off to care for il l  child (min, max)* 8  1.6 ( 1,  3) 61  2.2 ( 1,  7) 14  2.9 ( 1,  6) 5  1.6 ( 1,  2)
Percent of i l l  adults taking time off work/education for their i l lness 1723 11% 1169 26% 99 31% 15 20%
Among i ll  adults taking time off: Average number of days they take time off 
work/education(min, max) 184  2.6 ( 1, 14) 303  3.3 ( 1, 18) 31  3.8 ( 1,  9) 3  3.0 ( 2,  4)
Percent of i l lnesses where someone else takes time off to care for i l l  adult* 319 3% 535 7% 39 10% 5 0%
Among i llnesses where someone else takes time off: Average number of days they take 
time off to care for il l  adult (min, max)* 11  1.2 ( 1,  2) 35  1.5 ( 1,  5) 4  2.0 ( 1,  3) 0 N/A
Percent of i l l  older adults taking time off work/education for their il lness 409 5% 270 9% 8 13% 4 0%
Among i ll  older adults taking time off: Average number of days they take time off 
work/education (min, max) 19  3.4 ( 1,  7) 23  5.3 ( 1, 14) 1  3.0 ( 3,  3) 0 N/A
Percent of i l lnesses where someone else takes time off to care for i l l  older adult* 61 0% 105 6% 4 0% 0    .%
Among i llnesses where someone else takes time off: Average number of days they take 
time off to care for il l  older adult (min, max)* 0 N/A 6  2.5 ( 1,  5) 0 N/A 0 N/A
Percent of i l l  working adults taking time off work/education for their i l lness 1267 12% 785 30% 62 34% 9 33%
Among i ll  working adults taking time off: Average number of days they take time off 
work/education (min, max) 155  2.6 ( 1, 14) 233  3.3 ( 1, 18) 21  4.0 ( 1,  9) 3  3.0 ( 2,  4)
Percent of i l lnesses where someone else takes time off to care for i l l  working adult* 235 4% 361 6% 24 13% 2 0%
Among i llnesses where someone else takes time off: Average number of days they take 
time off to care for il l  working adult (min, max)* 10  1.2 ( 1,  2) 23  1.2 ( 1,  3) 3  2.3 ( 2,  3) 0 N/A
Ill Children
(0-15 years)**
Ill Adults
(16-64 years)**
Ill Older Adults
(65+ years)**
Ill Working 
Adults
(16+ years)**
* Estimates limited to subset of data where  time off work/education information was collected for both il l  participant and anyone caring for them
** Age group missing for 2 Influenza A cases, 7 ILI cases and 25 ARI cases
ARI ILI Flu A PCR+ Flu B PCR+
Overall
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Figure 1a-d.  EQ-5D-3L domains comparing baseline and worst day of illness (for the respective domain) for (a) ARI 
(b) ILI, (c) H1N1pdm09 and (d) Influenza B illnesses. 
a) 
 
b) 
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Figure 2. EQ-VAS and EQ-5D QALD weights comparing background and worst day of illness by illness outcome 
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Table 3. Impact on Health Related Quality of Life (Winter 2010/11) 
 
N Estimate N Estimate N Estimate N Estimate
Duration of symptoms, mean (min-max, median) 413  7.5 ( 1-42,  6.0) 256  9.9 ( 1-65,  7.0) 35  8.8 ( 1-26,  7.0) 23 11.9 ( 1-65,  7.0)
VAS background, mean (min-max, median) 408 89.0 (50-100, 90.0) 248 85.0 (25-100, 90.0) 34 89.8 (25-100, 90.0) 22 84.1 (40-100, 90.0)
VAS worst day of illness, mean (min-max, median) 413 66 ( 4-100, 70) 256 51 ( 0-90, 50) 35 43 ( 3-90, 40) 23 43 ( 5-75, 50)
EQ-5D weight background, mean (min-max, median) 406 0.92 (0.20-1.00, 1.00) 246 0.87 (-0.02-1.00, 1.00) 34 0.93 (0.25-1.00, 1.00) 21 0.92 (0.16-1.00, 1.00)
EQ-5D weight day of illness, mean (min-max, median) 413 0.77 (-0.54-1.00, 0.80) 256 0.48 (-0.59-1.00, 0.69) 35 0.44 (-0.43-1.00, 0.73) 23 0.36 (-0.59-1.00, 0.36)
QALDs lost, mean (min-max, median) 405 0.26 (-5.32-11.47, 0.20) 246 0.93 (-25.28-14.48, 0.74) 34 1.61 (-0.92-6.66, 1.00) 21 1.84 (-2.72-10.83, 1.14)
By Age group
0-15 84 0.24 (-2.72-7.22, 0.00) 71 0.20 (-25.28-4.65, 0.66) 7 1.08 (0.00-4.27, 0.20) 10 1.82 (0.58-3.27, 1.86)
16-65 257 0.34 (-5.32-11.47, 0.20) 137 1.30 (-4.72-14.48, 0.82) 23 1.74 (-0.92-6.66, 1.15) 7 2.37 (-0.84-10.83, 1.02)
65+ 64 -0.03 (-5.02-3.37, 0.00) 38 0.99 (-3.58-7.96, 0.74) 4 1.75 (-0.78-5.47, 1.15) 4 0.95 (-2.72-3.15, 1.68)
QALYs lost, mean (min-max, median) 405 0.0007 (-0.0146-0.0314, 0.0006) 246 0.0026 (-0.0692-0.0397, 0.0020) 34 0.0044 (-0.0025-0.0182, 0.0027) 21 0.0050 (-0.0074-0.0296, 0.0031)
By Age group
0-15 84 0.0007 (-0.0075-0.0198, 0.0000) 71 0.0005 (-0.0692-0.0127, 0.0018) 7 0.0029 (0.0000-0.0117, 0.0006) 10 0.0050 (0.0016-0.0090, 0.0051)
16-65 257 0.0009 (-0.0146-0.0314, 0.0006) 137 0.0035 (-0.0129-0.0397, 0.0022) 23 0.0048 (-0.0025-0.0182, 0.0032) 7 0.0065 (-0.0023-0.0296, 0.0028)
65+ 64 -0.0001 (-0.0138-0.0092, 0.0000) 38 0.0027 (-0.0098-0.0218, 0.0020) 4 0.0048 (-0.0021-0.0150, 0.0032) 4 0.0026 (-0.0074-0.0086, 0.0046)
QALDs lost (sensitivity analysis), mean (min-max, 405 0.72 (0.00-11.47, 0.41) 246 1.97 (0.00-16.33, 1.15) 34 1.89 (0.00-7.12, 1.09) 21 2.64 (0.00-10.83, 1.46)
By Age group
0-15 84 0.54 (0.00-7.22, 0.20) 71 1.68 (0.00-7.98, 1.03) 7 1.08 (0.00-4.27, 0.20) 10 1.82 (0.58-3.27, 1.86)
16-65 257 0.77 (0.00-11.47, 0.47) 137 2.02 (0.00-14.48, 1.27) 23 1.98 (0.20-6.66, 1.22) 7 2.80 (0.00-10.83, 1.02)
65+ 64 0.74 (0.00-7.17, 0.41) 38 2.37 (0.00-16.33, 1.04) 4 2.81 (0.19-7.12, 1.97) 4 4.41 (0.84-7.17, 4.81)
QALYs lost (sensitivity analysis), mean (min-max, 405 0.0020 (0.0000-0.0314, 0.0011) 246 0.0054 (0.0000-0.0447, 0.0031) 34 0.0052 (0.0000-0.0195, 0.0030) 21 0.0072 (0.0000-0.0296, 0.0040)
By Age group
0-15 84 0.0015 (0.0000-0.0198, 0.0006) 71 0.0046 (0.0000-0.0218, 0.0028) 7 0.0029 (0.0000-0.0117, 0.0006) 10 0.0050 (0.0016-0.0090, 0.0051)
16-65 257 0.0021 (0.0000-0.0314, 0.0013) 137 0.0055 (0.0000-0.0397, 0.0035) 23 0.0054 (0.0006-0.0182, 0.0034) 7 0.0077 (0.0000-0.0296, 0.0028)
65+ 64 0.0020 (0.0000-0.0196, 0.0011) 38 0.0065 (0.0000-0.0447, 0.0028) 4 0.0077 (0.0005-0.0195, 0.0054) 4 0.0121 (0.0023-0.0196, 0.0132)
ARI ILI H1N1pdm09 PCR+ Flu B PCR+
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Figure 3a-b. VAS and EQ-5D-3L QALD weight at baseline and by day of illness for (a) H1N1pdm09 illnesses and (b) 
Influenza B illnesses over the number of cases reporting symptoms on that day   
a) 
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Table 4.  Population-level burden of HRQoL lost and work/education absences due to community 
cases of influenza 
 
 
 
 
 
 
Outcome Age group Flu Type Estimate 95% CI
Overall A+B 24,300          16,600 – 34,700
By age group
0-15 A+B 6,410            3,640 – 10,900
16-64 A+B 16,200          9,710 – 25,800
65+ A+B 1,660            490 – 4,860
Overall A+B 2,910,000 2,090,000 - 3,930,000
By age group and flu type
A 949,000 528,000 - 1,580,000
B 1,760,000 1,140,000 - 2,610,000
A 170,000 52,300 - 414,000
B 27,600 4,720 - 89,100
5-15
16-65
QALY loss
Days off 
work/education
